Journal of Thyroid Cancer

Aims And Scope

The Journal of Thyroid Cancer (JTC) is an open access, peer-reviewed academic journal dedicated to advancing the understanding of thyroid cancer. This journal promotes research by providing an international platform for the publication of original and innovative articles in the field of thyroid cancer. The topics covered in the journal include clinical and translational studies, epidemiology, pathology, molecular biology, genetics, clinical trials, and epidemiologic and clinical studies. JTC is dedicated to the advancement of knowledge in all aspects of clinical and basic science related to the diagnosis, treatment, and outcome of thyroid cancer.

JTC publishes original research articles, review articles, case reports, clinical and laboratory studies, technical notes and letters to the editor. JTC particularly seeks articles related to diagnostic and therapeutic options, as well as controversies, novel approaches and theories, and general thyroid cancer research. All articles published in the journal are subject to a rigorous peer-review process that ensures quality and accuracy of the published work.

The journal is a platform for the exchange of ideas and discussions between health professionals and researchers in the field of thyroid cancer. The journal encourages contributions from authors from different parts of the world and different fields of expertise in order to promote meaningful dialogue. In addition to publishing original research, JTC feature reviews, commentaries, and special issues dedicated to individual topics related to thyroid cancer.

The primary aims of the Journal of Thyroid Cancer are to provide a comprehensive, international platform to stimulate and facilitate research on thyroid cancer and provide an opportunity for the exchange of current research findings, advances in clinical practice, and tools and techniques used in the diagnosis and management of this condition. The journal further aims to bridge research and clinical practice, to provide a better understanding of thyroid cancer and its clinical management, to foster the sharing of knowledge between medical professionals and researchers, and to promote evidence-based practice in the field.

Contributions from the following research areas are invited but not limited to the following branches 

• Metformin
• Glutathione
• Thyroid Cancer
• Immunotherapy
• Pathophysiology
• Thyroidectomy
• Transcription factors
• Radioactive iodine therapy
• Minimally invasive surgery
• Immune checkpoint inhibitors
• Thyroid carcinoma
• Radioiodine therapy
• Tumor size
• Distant metastasis
• Prognostic factors
• Molecular Immunology
• Tumor immune microenvironment
• Resistance to thyroid hormone
• Role of Hormones
• Diagnostic techniques
• Neoplasm metastasis
• Treatment of medullary thyroid cancer
• Differentiated thyroid cancer (DTC)
• Thyroid-stimulating hormone suppression therapy
• Differentiated thyroid cancers
• Papillary thyroid cancer
• Follicular thyroid cancer
• Medullary thyroid cancer
• Anaplastic thyroid cancer
• Hurthle cell thyroid cancer
• Genetic mutations
• BRAF mutation
• RET mutation
• TERT mutation
• Ionizing radiation
• Lymph node dissection
• Adjuvant therapy
• Chemotherapy
• Targeted therapy
• Hormone therapy
• Recurrent thyroid cancer
• Metastatic thyroid cancer
• Diagnostic tests
• Thyroid ultrasound
• Fine-needle aspiration biopsy
• Thyroid function tests
• Thyroid hormone replacement therapy
• Radioactive iodine scan
• Computed tomography (CT) scan
• Magnetic resonance imaging (MRI)
• Positron emission tomography (PET) scan
• Blood tests
• Molecular testing
• Next-generation sequencing
• Liquid biopsy
• Imaging-guided biopsy
• Endoscopic ultrasound-guided biopsy
• Multimodal treatment
• Surgery followed by radioactive iodine therapy
• Surgery followed by adjuvant therapy
• Adjuvant therapy followed by surgery
• Management of advanced disease
• Molecular targeted therapy
• Tyrosine kinase inhibitors
• Combination therapy